183 related articles for article (PubMed ID: 31495925)
1. Anticholinergic medications for reducing drooling in children with developmental disability.
Reid SM; Westbury C; Guzys AT; Reddihough DS
Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
[TBL] [Abstract][Full Text] [Related]
2. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
[TBL] [Abstract][Full Text] [Related]
3. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
Trials; 2014 Feb; 15():60. PubMed ID: 24533890
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study of glycopyrrolate in the management of drooling.
Stern LM
J Paediatr Child Health; 1997 Feb; 33(1):52-4. PubMed ID: 9069045
[TBL] [Abstract][Full Text] [Related]
5. Glycopyrrolate for chronic drooling in children.
Eiland LS
Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
[TBL] [Abstract][Full Text] [Related]
6. Glycopyrrolate treatment of chronic drooling.
Blasco PA; Stansbury JC
Arch Pediatr Adolesc Med; 1996 Sep; 150(9):932-5. PubMed ID: 8790123
[TBL] [Abstract][Full Text] [Related]
7. Glycopyrrolate for drooling in children with medical complexity under three years of age.
Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
[TBL] [Abstract][Full Text] [Related]
8. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy.
Reddihough D; Johnson H; Staples M; Hudson I; Exarchos H
Dev Med Child Neurol; 1990 Nov; 32(11):985-9. PubMed ID: 2269408
[TBL] [Abstract][Full Text] [Related]
9. The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities.
Reid SM; Johnson HM; Reddihough DS
Dev Med Child Neurol; 2010 Feb; 52(2):e23-8. PubMed ID: 19843155
[TBL] [Abstract][Full Text] [Related]
10. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
Bachrach SJ; Walter RS; Trzcinski K
Clin Pediatr (Phila); 1998 Aug; 37(8):485-90. PubMed ID: 9729704
[TBL] [Abstract][Full Text] [Related]
11. Transdermal scopolamine for reduction of drooling in developmentally delayed children.
Lewis DW; Fontana C; Mehallick LK; Everett Y
Dev Med Child Neurol; 1994 Jun; 36(6):484-6. PubMed ID: 7516297
[TBL] [Abstract][Full Text] [Related]
12. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
[TBL] [Abstract][Full Text] [Related]
13. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
[TBL] [Abstract][Full Text] [Related]
14. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.
Jongerius PH; van Tiel P; van Limbeek J; Gabreëls FJ; Rotteveel JJ
Arch Dis Child; 2003 Oct; 88(10):911-4. PubMed ID: 14500313
[TBL] [Abstract][Full Text] [Related]
15. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
16. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
Montgomery J; McCusker S; Lang K; Grosse S; Mace A; Lumley R; Kubba H
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():33-9. PubMed ID: 27240493
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
[TBL] [Abstract][Full Text] [Related]
18. Management of drooling in disabled patients with scopolamine patches.
Mato A; Limeres J; Tomás I; Muñoz M; Abuín C; Feijoo JF; Diz P
Br J Clin Pharmacol; 2010 Jun; 69(6):684-8. PubMed ID: 20565460
[TBL] [Abstract][Full Text] [Related]
19. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer.
Olsen AK; Sjøgren P
J Pain Symptom Manage; 1999 Oct; 18(4):300-2. PubMed ID: 10534970
[TBL] [Abstract][Full Text] [Related]
20. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N
Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]